『SE01 E05 From Insight to Impact: Serving Pharma Better in Drug Delivery | Nadine Brun』のカバーアート

SE01 E05 From Insight to Impact: Serving Pharma Better in Drug Delivery | Nadine Brun

SE01 E05 From Insight to Impact: Serving Pharma Better in Drug Delivery | Nadine Brun

無料で聴く

ポッドキャストの詳細を見る
This interview contains the personal and professional opinions of Nadine Brun which are not necessarily those of BD or any of its affiliates.Nadine Brun, recently appointed Vice President, Greater Asia, Pharmaceutical Systems at BD, and formerly VP Global Marketing & Strategy for BD Pharmaceutical Systems, brings over 20 years of experience in clinical diagnostics and life sciences to a conversation about what it really takes to serve pharma customers well. Drawing on the parallels between diagnostics and drug delivery — regulation, time to market, and patient outcomes at the center of both — Nadine shares how her background shaped a systems-level approach to combination product development. She unpacks the tension at the heart of the industry: unprecedented scientific innovation on one side, and deep resistance to change on the other, and why that gap is only going to matter more as biologics and complex therapies become the norm...etc.The conversation covers the real difference between what pharma customers ask for and what they actually need, how to de-risk drug development from early-stage material selection all the way through to commercial supply, and why co-creation with the right partners at the right time is the fastest route to market — not a slower one. Nadine also shares her definition of genuine thought leadership in pharma, what a strong operating model looks like when you are bridging technical and commercial teams, and the one piece of advice she would give any pharma company before they engage a device supplier.Key takeaways:Clinical diagnostics and pharma share more than people think — regulation, time-to-market pressure, and patient well-being as the core objective are common threadsThe biggest paradox in pharma right now is the push for scientific innovation running alongside deep institutional resistance to changeLarge established pharma and emerging biotech have fundamentally different needs from suppliers — one size does not fit all, and a strong operating model reflects thatDe-risking is not just about early-stage testing — it is an end-to-end process that includes scalable supply capacity from day oneCo-creation with the right expertise around the table — MedTech, pharma, machine makers, service providers — is what actually accelerates development, not what slows it downMarketers in technical environments need genuine scientific knowledge; removing that understanding makes it impossible to serve customers wellThought leadership means identifying customer pain points, building solutions around them, and being willing to take the innovation risks that drive the market forwardNPS surveys and structured customer feedback are practical tools for aligning what you offer with what different customer segments actually valueEngage your supplier partner at the earliest possible stage — waiting until phase two or later to think about regulatory affairs or supply chain is one of the most common and costly mistakes in combination product developmentConnect with Nadine Brun on LinkedIn: https://www.linkedin.com/in/nadine-brun-8515011/I hope you enjoy this episode! Give it a like, share, and subscribe to not miss the content coming your way weekly.– Parth & Jonathan and the Navigating the Combination podcast teamConnect with Parth Kothari on LinkedIn: https://www.linkedin.com/in/parthjkothari/ Connect with Jonathan Amaya-Hodges on LinkedIn: https://www.linkedin.com/in/jonathanwhodges/ Visit the Suttons Creek website here: https://suttonscreek.comListen to Navigating the Combination on these podcast platforms: Spotify: https://open.spotify.com/show/033HRTwEj7aFLx9K8ZEsVGApple Podcasts: https://podcasts.apple.com/us/podcast/navigating-the-combination/id6786238670Amazon Podcasts: https://music.amazon.com/podcasts/12169e2d-2323-41db-bdb4-8a8e7841c799#navigatingthecombination #suttonscreek #combinationproducts #drugdelivery #pharmaconsulting #regulatoryaffairs #medicaldevices #biotech #pharmabiotech #fdaregulation #drugdevicedevelopment #lifesciences #combinationproductdevelopment #pharmapodcast #devicestrategyNavigating the Combination is the podcast for pharmaceutical and biotech professionals tackling one of the industry's most complex challenges: bringing drug-device combination products to market. Hosted by Parth Kothari and Jonathan Amaya-Hodges of Suttons Creek - the device team for pharma - each episode draws on 650+ combined years of experience and 120+ successful launches to cut through the complexity of combination product development, from device selection and regulatory strategy to OEM alignment, quality systems, and FDA submissions.Whether you're a VP of Regulatory Affairs weighing your submission strategy, a program director managing a complex OEM relationship, or an executive trying to protect a multi-million-dollar drug investment, this podcast gives you the insight, clarity, and confidence to make the right calls - right the first time.
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません